Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madelain

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Antiviral Research|March 6, 2020
Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primatesVincent Madelain, Aurélie Duthey, France Mentré, et al.
Plos Computational Biology|September 10, 2024
Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo dataBharadwaj Vemparala, Vincent Madelain, Caroline Passaes, et al.
Plos Neglected Tropical Diseases|February 24, 2017
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targetedThi Huyen Tram Nguyen, Jérémie Guedj, Xavier Anglaret, et al.
Cell Reports|September 23, 2020
Optimal Maturation of the SIV-Specific CD8<sup>+</sup> T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC StudyCaroline Passaes, Antoine Millet, Vincent Madelain, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Antiviral Research|March 6, 2020
Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primatesVincent Madelain, Aurélie Duthey, France Mentré, et al.
Plos Computational Biology|September 10, 2024
Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo dataBharadwaj Vemparala, Vincent Madelain, Caroline Passaes, et al.
Plos Neglected Tropical Diseases|February 24, 2017
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targetedThi Huyen Tram Nguyen, Jérémie Guedj, Xavier Anglaret, et al.
Cell Reports|September 23, 2020
Optimal Maturation of the SIV-Specific CD8<sup>+</sup> T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC StudyCaroline Passaes, Antoine Millet, Vincent Madelain, et al.
Pageof 14